Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Leukemia and Lymphoma

• Publication date

  1994-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10428199409051674PMID 7858500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

  2004cited by this paper
• Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors

  1994cited by this paper
• Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death).

  1993cited by this paper
• Cancer. A death in the life of p53.

  1993cited by this paper
• A morphological and immunohistochemical study of programmed cell death in Botryllus schlosseri (Tunicata, Ascidiacea)

  1993cited by this paper
• A death in the life of p53

  1993cited by this paper
• Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.

  1993cited by this paper
• Identification of deoxyribonuclease II as an endonuclease involved in apoptosis.

  1993cited by this paper
• Chelation of intracellular zinc triggers apoptosis in mature thymocytes.

  1993cited by this paper
• Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.

  1993cited by this paper
• The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow

  1993cited by this paper
• DNA fragmentation induced by cytotoxic T lymphocytes can result in target cell death.

  1993cited by this paper
• Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol-ester-induced monocytic differentiation by dexamethasone and cyclosporin A: potential involvement of a destabilizing protein.

  1993cited by this paper
• Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.

  1993cited by this paper
• Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.

  1993cited by this paper
• Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity.

  1993cited by this paper
• The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.

  1993cited by this paper
• Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

  1993cited by this paper
• Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.

  1993cited by this paper
• Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation.

  1993cited by this paper
• Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.

  1993cited by this paper
• When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs.

  1993cited by this paper
• Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• Signaling for death of lymphoid cells.

  1993cited by this paper
• bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.

  1993cited by this paper
• Control of programmed cell death in normal and leukemic cells: new implications for therapy.

  1993cited by this paper
• Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines.

  1993cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis

  1993cited by this paper
• Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.

  1993cited by this paper
• High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.

  1993cited by this paper
• Programmed cell death induced by ceramide.

  1993cited by this paper
• Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.

  1993cited by this paper
• Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells.

  1993cited by this paper
• SGP2, ubiquitin, 14K lectin and RP8 mRNAs are not induced in neuronal apoptosis

  1993cited by this paper
• Molecular regulation of apoptosis: genetic controls on cell death.

  1993cited by this paper
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

  1993cited by this paper
• Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4.

  1993cited by this paper
• bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.

  1993cited by this paper
• DNA fragmentation during apoptosis is caused by frequent single-strand cuts.

  1993cited by this paper
• Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.

  1993cited by this paper
• Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification.

  1993cited by this paper
• Mechanism of tissue-specific induction of internucleosomal deoxyribonucleic acid cleavage activity and apoptosis by glucocorticoids.

  1993cited by this paper
• Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiat

  1992cited by this paper
• Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions

  1992cited by this paper
• Cell death by apoptosis and its protective role against disease.

  1992cited by this paper
• Teniposide induces nuclear but not mitochondrial DNA degradation.

  1992cited by this paper
• Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester.

  1992cited by this paper
• The apoptosis endonuclease and its regulation.

  1992cited by this paper
• cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway.

  1992cited by this paper
• The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?

  1992cited by this paper
• Molecular genetics of cell death in the nematode Caenorhabditis elegans.

  1992cited by this paper
• Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines.

  1992cited by this paper
• Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH.

  1992cited by this paper
• A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome

  1992cited by this paper
• Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A.

  1992cited by this paper
• bcl-2 gene expression in hematopoietic cell differentiation.

  1992cited by this paper
• Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.

  1992cited by this paper
• A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells?

  1992cited by this paper
• Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells

  1992cited by this paper
• Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells.

  1992cited by this paper
• Inhibition of apoptosis by zinc: a reappraisal.

  1992cited by this paper
• Radiolabeling of DNA can induce its fragmentation in HL-60 human promyelocytic leukemic cells.

  1992cited by this paper
• Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle.

  1992cited by this paper
• Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation.

  1992cited by this paper
• Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells.

  1992cited by this paper
• A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells

  1992cited by this paper
• bcl-2 gene expression in hematopoietic cell differentiation

  1992cited by this paper
• The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.

  1991cited by this paper
• Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.

  1991cited by this paper
• Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells.

  1991cited by this paper
• Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.

  1991cited by this paper
• Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.

  1991cited by this paper
• Response to adversity: molecular control of gene activation following genotoxic stress.

  1991cited by this paper
• Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

  1991cited by this paper
• Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

  1991cited by this paper
• Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.

  1991cited by this paper
• Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.

  1991cited by this paper
• A DNA topoisomerase I inhibitor blocks the differentiation of rat granulosa cells induced by follicle-stimulating hormone.

  1991cited by this paper
• Ultraviolet B irradiation of human leukaemia HL-60 cells in vitro induces apoptosis.

  1991cited by this paper
• Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.

  1991cited by this paper
• Topoisomerase Inhibitors Have Potent Differentiation‐inducing Activity for Human and Mouse Myeloid Leukemia Cells

  1991cited by this paper
• Studies of the differentiation properties of camptothecin in the human leukaemic cells K562.

  1991cited by this paper
• Spermine prevents endonuclease activation and apoptosis in thymocytes.

  1991cited by this paper
• Epipodophyllotoxin‐related leukemia. Identification of a new subset of secondary leukemia

  1991cited by this paper
• Programmed death of nonproliferating androgen-independent prostatic cancer cells.

  1991cited by this paper
• Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. NUC18 is not histone H2B.

  1991cited by this paper
• Mechanisms and functions of cell death.

  1991cited by this paper
• Dose‐dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli

  1991cited by this paper
• New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

  1991cited by this paper
• Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.

  1991cited by this paper
• Disassembly of chromatin into approximately equal to 50 kb units by detergent.

  1990cited by this paper
• Disassembly of chromatin into ≅50 kb units by detergent

  1990cited by this paper
• Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

  1990cited by this paper
• Apoptosis. The role of the endonuclease.

  1990cited by this paper
• HL‐60 cells induced to differentiate towards neutrophils subsequently die via apoptosis

  1990cited by this paper
• Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.

  1990cited by this paper

• In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer

  2021cites this paper
• Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds

  2020cites this paper
• New Medical Applications of Plant Secondary Metabolites (From APR Volume 3)

  2018cites this paper
• In Vitro Topoisomerase II Inhibitory and Apoptotic Activities of Novel 3,5 Disubstituted Thiophene-2-carboxylates

  2016cites this paper
• Cryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway.

  2016cites this paper
• Recent Synthetic Approaches to Anti-cancer 9-Anilinoacridines. A Review

  2012cites this paper
• Topoisomerases and Apoptosis

  2012cites this paper
• An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II

  2011cites this paper
• Vacuolization and apoptosis induced by nano-selenium in HeLa cell line

  2010cites this paper
• Topoisomerase II inhibition by the bioactivated benzene metabolite hydroquinone involves multiple mechanisms.

  2010cites this paper
• Recombinant human PDCD5 protein enhances chemosensitivities of hematologic malignancies

  2009cites this paper
• Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies.

  2009cites this paper
• JWA Sensitizes P-Glycoprotein-Mediated Drug-Resistant Choriocarcinoma Cells to Etoposide VIA JNK and Mitochondrial-Associated Signal Pathway

  2009cites this paper
• Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment

  2008cites this paper
• Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells.

  2008cites this paper
• Topoisomerase inhibitors as anti-arthritic agents

  2008cites this paper
• DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.

  2007cites this paper
• Replication-deficient adenovirus induces host topoisomerase I activity: implications for adenovirus-mediated gene expression.

  2007cites this paper
• Aging increases the susceptibility of skeletal muscle derived satellite cells to apoptosis.

  2006cites this paper
• Rb Inactivation Leads to E2F1-mediated DNA Double Strand Break Accumulation: A Dissertation

  2006cites this paper
• Boswellic acids: biological actions and molecular targets.

  2006cites this paper
• Endonuclease Activation and Chromosomal DNA Fragmentation during Apoptosis in Leukemia Cells

  2006cites this paper
• Camptothecin in Human Colon Carcinoma Cells Arrest and the Cytotoxicity of 2 Correlations between S and G Updated

  2006cites this paper
• The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.

  2005cites this paper
• Cell cycle and drug sensitivity.

  2005cites this paper
• The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells.

  2004cites this paper
• Isolation and characterization of mammalian cells that are undergoing apoptosis by a bovine serum albumin density gradient.

  2004cites this paper
• The effect of inhibiting topoisomerase I and II on the antiapoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils

  2003cites this paper
• Mechanism of action of topoisomerase II-targeted anticancer drugs

  2003cites this paper
• Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

  2003cites this paper
• Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.

  2003cites this paper
• Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.

  2003cites this paper
• cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide

  2003cites this paper
• Combined stimulation with interferon α and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12

  2002cites this paper
• Control of Mammary Tumor Cell Growth in Vitro by Novel Cell Differentiation and Apoptosis Agents

  2002cites this paper
• Atypical Protein Kinase C ζ as a Target for Chemosensitization of Tumor Cells

  2002cites this paper
• Durchflußzytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2002cites this paper
• A role for the subcellular localization of Bax in differentiation-induced resistance to apoptosis in HL-60 cells.

  2002cites this paper
• Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.

  2002cites this paper
• Skeletal muscle denervation increases satellite cell susceptibility to apoptosis.

  2002cites this paper
• DNA cleavage and religation by human topoisomerase II alpha at high temperature.

  2001cites this paper
• Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells.

  2001cites this paper
• DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells.

  2001cites this paper
• Killing tumour cells by alkylphosphocholines: evidence for involvement of CD95.

  2001cites this paper
• Apoptotic response of HL-60 human leukemia cells to the antitumor drug NB-506, a glycosylated indolocarbazole inhibitor of topoisomerase 1.

  2001cites this paper
• Excessive base excision repair of 5-hydroxymethyluracil from DNA induces apoptosis in Chinese hamster V79 cells containing mutant p53.

  2001cites this paper
• Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.

  2000cites this paper
• Initiation of DNA Fragmentation during Apoptosis Induces Phosphorylation of H2AX Histone at Serine 139*

  2000cites this paper
• Activity of crude extract ofRubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor

  2000cites this paper
• Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review).

  2000cites this paper
• Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.

  2000cites this paper
• Induction of apoptosis by dietary polyunsaturated fatty acids in human leukemic cells is not associated with DNA fragmentation.

  2000cites this paper
• Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

  2000cites this paper
• Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.

  2000cites this paper
• Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis.

  1999cites this paper
• Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells.

  1999cites this paper
• DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.

  1999cites this paper
• Regulation of p27Kip1 during gentamicin mediated hair cell death

  1999cites this paper
• Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

  1999cites this paper
• Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.

  1999influential citation
• DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.

  1999cites this paper
• Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines.

  1999cites this paper
• Acetyl-11-Keto-β-Boswellic Acid Induces Apoptosis in HL-60 and CCRF-CEM Cells and Inhibits Topoisomerase I

  1999cites this paper
• Diversity of DNA topoisomerases I and inhibitors.

  1998cites this paper
• Potential applications of cell cycle manipulation to clinical response.

  1998cites this paper
• Accumulation of cyclin B1, activation of cyclin B1‐dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol

  1998cites this paper
• Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol.

  1998cites this paper
• Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.

  1998cites this paper
• Advances in Radiation Therapy

  1998cites this paper
• Multiple Drug Resistance in Cancer 2

  1998cites this paper
• New insights into the kinetic resistance to anticancer agents

  1998cites this paper
• Induction of apoptosis in MCF-7: WS8 breast cancer cells by β-Lapachone

  1998cites this paper
• Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.

  1998cites this paper
• A Mutant Yeast Topoisomerase II (top2G437S) with Differential Sensitivity to Anticancer Drugs in the Presence and Absence of ATP*

  1998cites this paper
• Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis

  1998cites this paper
• Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.

  1998cites this paper
• Resistance to topoisomerase II poisons: is the answer in the promoter?

  1997cites this paper
• 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.

  1997cites this paper
• Topoisomerase I inhibitors: review and update.

  1997cites this paper
• Effects of actinomycin D on developing hamster molar tooth germs in vitro.

  1997cites this paper
• Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).

  1997cites this paper
• Factors Affecting Topotecan Sensitivity in Human Leukemia Samples a

  1996cites this paper
• Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.

  1996cites this paper
• Apoptosis in acute myeloblastic leukemia: follow-up study on trephine biopsies of the bone marrow.

  1996cites this paper
• Mutational specificity and cancer chemoprevention

  1996cites this paper
• Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53.

  1996cites this paper
• Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.

  1996cites this paper
• DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.

  1996cites this paper
• Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology.

  1996cites this paper
• Cell cycle dependence of drug initiated apoptosis in HL-60 cells.

  1996cites this paper
• Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes.

  1996cites this paper
• Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.

  1996cites this paper
• Cellular Resistance to Camptothecins

  1996cites this paper
• Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites.

  1996cites this paper
• Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.

  1996cites this paper
• Chemotherapeutic drug cytotoxicity enhancement in human cells in culture

  1996cites this paper
• [Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors].

  1996cites this paper
• Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc

  1996cites this paper
• Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.

  1996cites this paper